Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127252861 | 12725286 | 1 | I | 20160906 | 20160908 | 20160908 | EXP | US-009507513-1609USA002901 | MERCK | 0.00 | F | Y | 0.00000 | 20160908 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127252861 | 12725286 | 1 | PS | VYTORIN | EZETIMIBESIMVASTATIN | 1 | Oral | 1 TABLET (10/40 MG) DAILY | 21687 | 1 | DF | TABLET | QD | ||||||
| 127252861 | 12725286 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 1 TABLET (100 MG) DAILY | 0 | 100 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127252861 | 12725286 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127252861 | 12725286 | Adverse event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |